Satoshi Tatemichi Selected Research

silodosin

11/2022	Therapeutic effects of silodosin and urapidil on underactive bladder associated with diabetic cystopathy.
8/2017	Alpha1A-adrenoceptor antagonist improves underactive bladder associated with diabetic cystopathy via bladder blood flow in rats.
1/2016	Silodosin, an α(1A)-Adrenoceptor Antagonist, May Ameliorate Ischemia-Induced Bladder Denervation and Detrusor Dysfunction by Improving Bladder Blood Flow.
10/2015	Effect of silodosin, a selective α(1A)-adrenoceptor antagonist, on voiding behavior and bladder blood flow in a rat model of bladder outlet obstruction.
1/2015	Effects of Silodosin, an α1A-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats.
6/2009	Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.
9/2006	A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia.
3/2006	[Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia].
3/2006	[Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract].
1/2006	Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Tatemichi Research Topics

Disease

5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2023 - 01/2006
3	Type 2 Diabetes Mellitus (MODY) 12/2017 - 01/2015
3	Overactive Urinary Bladder (Overactive Bladder) 08/2012 - 01/2012
2	Underactive Urinary Bladder 11/2022 - 01/2015
2	Diabetes Mellitus 11/2022 - 08/2017
2	Secondary Hyperparathyroidism 01/2018 - 01/2017
2	Hyperphosphatemia 01/2018 - 01/2017
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 10/2015 - 01/2012
2	Hypotension (Low Blood Pressure) 06/2009 - 03/2006
2	Dysuria 03/2006 - 01/2006
1	Insulin Resistance 11/2023
1	Leiomyoma (Uterine Fibroids) 11/2023
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Endometriosis 11/2023
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2023
1	Anemia 01/2020
1	Iron Overload 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Airway Obstruction (Choking) 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 07/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2017
1	Atherosclerosis 01/2016
1	Ischemia 01/2016
1	Lower Urinary Tract Symptoms 06/2009

Drug/Important Bio-Agent (IBA)

11	silodosin FDA Link 11/2022 - 01/2006
3	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2015 - 03/2006
3	ritobegronIBA 08/2012 - 01/2012
2	Phosphates (Orthophosphate)IBA 01/2018 - 01/2017
2	IronIBA 01/2018 - 01/2017
2	mitiglinideIBA 12/2017 - 07/2017
2	Tamsulosin (Flomax)FDA LinkGeneric 06/2009 - 03/2006
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2023
1	linzagolixIBA 11/2023
1	Therapeutic UsesIBA 11/2022
1	urapidilIBA 11/2022
1	Darbepoetin alfa (Aranesp)FDA Link 01/2020
1	Erythropoietin FDA Link 01/2020
1	CarbohydratesIBA 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2020
1	Phosphorus (Red Phosphorus)IBA 01/2018
1	Sucrose (Saccharose)IBA 01/2018
1	sucroferric oxyhydroxideIBA 01/2018
1	TabletsIBA 01/2018
1	ferric oxyhydroxideIBA 01/2018
1	SymportersIBA 12/2017
1	Pioglitazone (Actos)FDA Link 12/2017
1	SecretagoguesIBA 12/2017
1	BiguanidesIBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	GlucosidasesIBA 12/2017
1	Insulin (Novolin)FDA Link 12/2017
1	SodiumIBA 12/2017
1	Sitagliptin Phosphate (Januvia)FDA Link 07/2017
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 07/2017
1	Blood Glucose (Blood Sugar)IBA 07/2017
1	Streptozocin (Streptozotocin)FDA Link 07/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2017
1	Glyburide (Glibenclamide)FDA LinkGeneric 07/2017
1	Niacinamide (Nicotinamide)FDA LinkGeneric 07/2017
1	CalciumIBA 01/2017
1	Adenine FDA LinkGeneric 01/2017
1	Sevelamer (RenaGel)FDA Link 01/2017
1	lanthanum carbonate (Fosrenol)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 10/2015
1	distigmine (distigmine bromide)IBA 01/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015
1	Tolterodine Tartrate (Detrol)FDA Link 01/2012
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 09/2006
1	Hormones (Hormone)IBA 09/2006
1	naftopidilIBA 03/2006
1	indoleIBA 01/2006

Therapy/Procedure

1	Therapeutics 01/2018
1	Denervation 01/2016